From October 1, 2023 to December 31, 2023, the company has repurchased 20,000 shares, representing 0.01% for CNY 1.07 million. With this, the company has completed the repurchase of 29,829 shares, representing 0.02% for CNY 1.59 million under the buyback announced on August 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.7 CNY | +0.66% |
|
-0.26% | -29.24% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.24% | 735M | |
+55.35% | 848B | |
+31.64% | 627B | |
-0.10% | 363B | |
+15.47% | 318B | |
+13.10% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.54% | 179B | |
+4.31% | 167B |
- Stock Market
- Equities
- 688513 Stock
- News Chengdu Easton Biopharmaceuticals Co., Ltd.
- Tranche Update on Chengdu Easton Biopharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on August 14, 2023.